ZA5-18230-74480
4 vaccinations
8 coded responses
42 check-ins
7 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Survey response — day 0, dose 1MedDRA: Dizziness, Immediate post-injection reaction — Feeling: Good · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness immediately following vaccine for 30 minutesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-18
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — day 7, dose 2Feeling: Fair · Headache, Diarrhea, Abdominal pain · Be unable to workAdult check-in
- 2021-01-15
- 2021-01-22
- 2021-01-29
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Emergency care, Headache, Ophthalmic migraine, Vision blurred — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Vision went blurry just over 3 weeks after 2nd dose. Spent an hour in the ER- may be an ocular migraine. I have never had any vision issues before receiving the vaccine- though I have had severe headaches so its possible I have undiagnosed migraiMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-14
Survey response — day 35, dose 2MedDRA: Dizziness — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Light headed frequentlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: Hypoaesthesia, Ophthalmic migraine — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Numbness in right ring and pinky finger. Continued ocular migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-02
- 2021-06-02
- 2021-06-02
- 2021-07-09
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-09
- 2021-10-14
- 2021-10-21
- 2021-10-30
- 2021-11-04
- 2021-11-11
- 2022-04-02
-
2022-10-06
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-09
-
2022-10-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-10-12
-
2022-10-13
Health check-in — day 7, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-10-20
- 2022-10-27
- 2022-11-03
-
2022-11-12
Survey response — day 35, dose 4MedDRA: Food intolerance, Gastrointestinal disorder — Feeling: GoodFree text: Digestive problems- sensitivity to most foodMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — day 42, dose 4MedDRA: Abdominal discomfort, Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Stomach upset and diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2023-01-11
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-06 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-18 | priority 2/3 | |
| 2020-12-20 | priority 2/3 | |
| 2021-01-13 | priority 2/3 | |
| 2021-01-15 | priority 2/3 | |
| 2021-02-05 | Unsuccessful | |
| 2021-02-14 | Unsuccessful | |
| 2021-04-09 | Unsuccessful |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Dizziness immediately following vaccine for 30 minutes
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Release 3 — day 28, dose 2
Symptoms: Vision went blurry just over 3 weeks after 2nd dose. Spent an hour in the ER- may be an ocular migraine. I have never had any vision issues before receiving the vaccine- though I have had severe headaches so its possible I have undiagnosed migrai
Release 4 — day 35, dose 2
Symptoms: Light headed frequently
Release 7 — 3 months, dose 2
Symptoms: Numbness in right ring and pinky finger. Continued ocular migraines
Release 12 — day 35, dose 4
Symptoms: Digestive problems- sensitivity to most food
Release 12 — day 42, dose 4
Symptoms: Stomach upset and diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Food intolerance | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ophthalmic migraine | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release